These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HZT-501 (DUEXIS(®); ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Schiff M, Peura D. Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):25-35. PubMed ID: 22149579 [Abstract] [Full Text] [Related]
3. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. Taha AS, Hudson N, Hawkey CJ, Swannell AJ, Trye PN, Cottrell J, Mann SG, Simon TJ, Sturrock RD, Russell RI. N Engl J Med; 1996 May 30; 334(22):1435-9. PubMed ID: 8618582 [Abstract] [Full Text] [Related]
5. Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritis. Kuan R, Holt RJ, Johnson KE, Kent JD, Peura DA, Malone D. Clin Ther; 2013 Mar 30; 35(3):321-32. PubMed ID: 23497762 [Abstract] [Full Text] [Related]
6. Risk of upper gastrointestinal ulcers in patients with osteoarthritis receiving single-tablet ibuprofen/famotidine versus ibuprofen alone: pooled efficacy and safety analyses of two randomized, double-blind, comparison trials. Bello AE, Kent JD, Grahn AY, Rice P, Holt RJ. Postgrad Med; 2014 Jul 30; 126(4):82-91. PubMed ID: 25141246 [Abstract] [Full Text] [Related]
9. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine. Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C. Aliment Pharmacol Ther; 2005 Jun 30; 21 Suppl 2():67-72. PubMed ID: 15943850 [Abstract] [Full Text] [Related]
11. [Prevention of NSAID induced gastroduodenal ulcers]. Hansen JM, Bytzer P. Ugeskr Laeger; 2001 Oct 29; 163(44):6103-5. PubMed ID: 11715151 [Abstract] [Full Text] [Related]
12. One-year open-label safety evaluation of the fixed combination of ibuprofen and famotidine with a prospective analysis of dyspepsia. Bello AE, Kent JD, Grahn AY, Ball J, Holt RJ. Curr Med Res Opin; 2015 Mar 29; 31(3):397-405. PubMed ID: 25495134 [Abstract] [Full Text] [Related]
13. One-year safety of ibuprofen/famotidine fixed combination versus ibuprofen alone: pooled analyses of two 24-week randomized, double-blind trials and a follow-on extension. Bello AE, Grahn AY, Ball J, Kent JD, Holt RJ. Curr Med Res Opin; 2015 Mar 29; 31(3):407-20. PubMed ID: 25516006 [Abstract] [Full Text] [Related]
14. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials. Koch M, Dezi A, Ferrario F, Capurso I. Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239 [Abstract] [Full Text] [Related]